Independent answers about GLP-1 medications, before and during treatment.
GLP-1 Healthcare helps you understand semaglutide, tirzepatide, and every option in between — costs, dosing, side effects, and how to find legitimate care. Independently operated, evidence-sourced, and free to use.
No pharmaceutical-manufacturer funding or sponsorship
Three places people arrive from
Most of what is here is useful at one particular point rather than all of them. Pick the sentence that sounds like you.
Start with what the trials actually found at your weight — the full spread of outcomes, with the placebo arm beside every figure, rather than one number somebody made up for you.
See the real range I want one — what is the cheapest honest route?Every route priced side by side, with membership fees added to the medication rather than advertised separately. Sources and dates on every figure.
Compare the real monthly totals I’m already taking oneSide effects and what settles, dose increases and why they flare, what to eat, and the symptoms worth calling someone about.
Managing treatmentBuilt from what people are actually asking
Every topic maps to real questions people search for, and is written to a single evidence standard. Guides are rolling out now.
What GLP-1 Healthcare is, and what it is not
GLP-1 Healthcare is an independent publisher of health information about GLP-1 medications. It is a website that explains what these drugs are, what they cost, what they do, and how to reach legitimate care — written for readers in the United States and operated by GLP-1 Healthcare Group.
Because the name suggests otherwise to some people, it is worth being explicit about what it is not. GLP-1 Healthcare is not a clinic, a pharmacy, a telehealth prescriber, or a pharmaceutical manufacturer. Nobody here can prescribe you anything, dispense anything, or access your medical records. If you arrived looking for treatment rather than information, the directory of telehealth providers lists companies that do prescribe, with what each one publishes about its own terms.
The site earns money through flat referral fees from providers listed in that directory. Flat means the fee does not change with the provider, which is why the directory is published unranked — there is no ordering for anyone to buy. No pharmaceutical manufacturer funds any part of it. That arrangement, and its limits, are set out in how we are funded.
No page here has been reviewed by a clinician, and every page says so at the top rather than in the small print. What the site does instead is trace every clinical figure to a named, dated primary source you can open yourself, and record the times it got something wrong in a public corrections log.
Authority you can check, not authority we claim
We don’t ask you to take our word for it. Every clinical claim is sourced to the recognised authorities, and our standards are public.
The full library of authorities we draw from — the FDA, the ADA, peer-reviewed trials, and more — organised by how much weight each carries.
See our sources →Editorial PolicyHow we research, write, source, and review content — and exactly what our “medically reviewed” label does and does not mean today.
Read the policy →How We’re FundedWhere our money comes from, and the line we will not cross: no manufacturer funding, and clear labelling of any commercial links.
See our funding →